SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib

Malignant melanoma is the most aggressive skin cancer and can only be cured if detected early. Unfortunately, later stages of the disease do not guarantee success due to the rapid rate of melanoma cell metastasis and their high resistance to applied therapies. The search for new molecular targets an...

Descripción completa

Detalles Bibliográficos
Autores principales: Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Sobalska-Kwapis, Marta, Walczak-Drzewiecka, Aurelia, Pułaski, Łukasz, Strapagiel, Dominik, Dastych, Jarosław, Ratajewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562913/
https://www.ncbi.nlm.nih.gov/pubmed/31091806
http://dx.doi.org/10.3390/cancers11050673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562913/
https://www.ncbi.nlm.nih.gov/pubmed/31091806
http://dx.doi.org/10.3390/cancers11050673

Ejemplares similares